Senate Medicaid Supplemental Rebate Amendment May Block PhRMA Suits

An amendment to generic drug legislation in the Senate would eliminate the Pharmaceutical Research & Manufacturers of America's ability to challenge state Medicaid programs' use of supplemental drug rebates for residents not eligible for Medicaid